待处理
入排:排除
图源:待检查
入排置信度 0.99
Ixekizumab provides persistent improvements in health-related quality of life and the sexual impact associated with moderate-to-severe genital psoriasis in adult patients during a 52-week, randomised, placebo-controlled, phase 3 clinical trial.
C Ryan, L Guenther, P Foley, J Weisman, R T Burge, G Gallo, K See, M McKean-Matthews, C C Bertram, J F Merola
J Eur Acad Dermatol Venereol 36(4) e277-e279
入排依据:记录类型属于综述、Meta 分析、社论、评论、病例或指南。
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板